Patterns of relapse in breast cancer: Changes over time

Breast Cancer Research and Treatment

Volumn 120, Issue 3, 2010, Pages 753-759

  Yerushalmi, Rinat ^a   Woods, Ryan ^a   Kennecke, Hagen ^a   Speers, Caroline ^a   Knowling, Meg ^a   Gelmon, Karen ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anthracyclines; Bone; ER negative; ER positive; Pattern of relapse; Site of metastasis; Visceral

Indexed keywords

ANTHRACYCLINE DERIVATIVE; TAMOXIFEN;

ADULT; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RELAPSE; CANCER STAGING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISTANT METASTASIS; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; BREAST NEOPLASMS; BRITISH COLUMBIA; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; ESTROGENS; FEMALE; HUMANS; INCIDENCE; MASTECTOMY; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; ORGAN SPECIFICITY; POSTMENOPAUSE; PREMENOPAUSE; RADIOTHERAPY, ADJUVANT; REGISTRIES;

EID: 77950864810     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0510-2     Document Type: Article

References (23)

1. Citron ML, Berry DA, Cirrincione C et al (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741/Cancer and leukemia group B trial 9741. J Clin Oncol 21:1431-1439 (Pubitemid 46594092)
2. Perez E, Muss HB (2005) Optimizing adjuvant chemotherapy in early-stage breast cancer. Oncology (Williston Park) 19:1759-1767 discussion 1768, 1772-4, 1777-1778
3. Lin NU, Winer EP (2008) Advances in adjuvant endocrine therapy for postmenopausal women. J Clin Oncol 26:798-805 (Pubitemid 351264393)
4. De Laurentiis M, Cancello G, D' Agostino D et al (2008) Taxanebased combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials. J Clin Oncol 26:44-53
5. Dahabreh IJ, Linardou H, Siannis F et al (2008) Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials. Oncologist 13:620-630 (Pubitemid 351904907)
6. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747-752
7. GoldhirschA,GelberRD,CastiglioneM(1988) Relapseofbreastcancerafteradjuvanttreatmentinpremenopausalandperimenopausalwome n:patternsandprognoses.JClinOncol6:89-97(Pubitemid18039996)
8. Perez JE, Machiavelli M, Leone BA et al (1990) Bone-only versus visceral-only metastatic pattern in breast cancer: analysis of 150 patients. A GOCS study. grupo oncologico cooperativo del sur. Am J Clin Oncol 13:294-298
9. ColemanRE,SmithP,RubensRD(1998) Clinicalcourseandprognosticfactorsfollowingbonerecurrencefrombreastcancer. BrJCancer77:336-340(Pubitemid28029553)
10. Pintilie M (2006) Competing risks: a practical perspective. Wiley, New York
11. Gray RJ (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154
12. Casella G, Berger RL (1990) Statistical inference. Duxbury Press, Belmont, pp 328-331
13. Davison AC, Davison DV (1997) Bootstrap methods and their application. Cambridge University Press, Cambridge, pp 82-87
14. Smalley RV, Scogna DM, Malmud LS (1982) Advanced breast cancer with bone-only metastases: a chemotherapeutically responsive pattern of metastases. Am J Clin Oncol 5:161-166
15. Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13:4429-4434 (Pubitemid 47219710)
16. Hess KR, Pusztai L, Buzdar AU et al (2003) Estrogen receptors and distinct patterns of breast cancer relapse. Breast Cancer Res Treat 78:105-118 (Pubitemid 36223023)
17. Pritchard K (1994) Adjuvant systemic therapy for early breast cancer: a tale of relapse and survival. Lancet 343:370-371 (Pubitemid 24049550)
18. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687-1717 (Pubitemid 40719106)
19. Crabb SJ, Cheang MC, Leung S et al (2008) Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer, Clin Breast Cancer 8:249-256 (Pubitemid 351962146)
20. Whatcheressian JL, Wolff AC, Smith TJ (2006) American society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24:5091-5097
21. Diel IJ, Jaschke A, Solomayer EF et al (2008) Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up. Ann Oncol 19:2007-2011
22. Powles T, Paterson A, McCloskey E et al (2006) Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Res 8:R13 (Pubitemid 44376864)
23. Saarto T, Vehmanen L, Virkkunen P et al (2004) Ten-year followup of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients. Acta Oncol 43:650-656 (Pubitemid 39563937)